Aclarion to showcase groundbreaking nociscan technology at the 2025 spine summit

Dr. nicholas theodore to highlight nociscan capabilities combining mr spectroscopy and augmented intelligence (ai)  nociscan is an innovative decision support tool that helps physicians personalize treatment for chronic low back pain broomfield, colo., feb. 20, 2025 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the 2025 spine summit.
ACON Ratings Summary
ACON Quant Ranking